Identified a genetic marker that indicates the severity of the disease
A genetic variant associated with faster progression of multiple sclerosis has been identified. The discovery was made by a team of Italian researchers from various centers: University of Eastern Piedmont, IRCCS San Raffaele Hospital in Milan, University of Milan, IRCCS Casa Sollievo della Sofferenza Foundation and ASST Santi Paolo e Carlo in Milan.
The study, involving more than 22,000 people with multiple sclerosis (MS), has discovered the first genetic variant associated with faster disease progression, which over time can deprive patients of their mobility and independence.
Multiple sclerosis is the result of the action of the immune system mistakenly attacking the brain and spinal cord causing flare-ups of symptoms, known as relapses, and long-term degeneration, known as progression, i.e. a buildup … (continue) read the 2nd page
News about: sclerosis, variant, gene, New discoveries for the treatment of multiple sclerosis Genetic marker that indicates the severity of the disease identified
Multiple Sclerosis, the silent progression Study examines PIRA, a phenomenon that affects many patients
New antibody slows multiple sclerosis Reduced disease activity due to unique mechanism of action
Multiple sclerosis, the targets common to the various forms Study identifies the targets to hit in each phase and form
Multiple sclerosis, the Mediterranean diet improves symptoms The diet helps preserve memory and cognitive abilities
Multiple sclerosis, biomarker predicts its progression The role of glial fibrillary acid protein (Gfap)
Multiple sclerosis, first neural stem therapy The mechanism by which cells function has been revealed
Multiple sclerosis, stem cells reduce disability in patients with secondary progressive forms
Understanding neurodegenerative diseases with X-ray Tomography useful for investigating the origin and evolution of multiple sclerosis
Multiple sclerosis, effective ozanimod Improves and preserves cognitive functions
Multiple sclerosis, effective ocrelizumab After 2 years, 80 percent of patients are in remission
A combo against multiple sclerosis Chemotherapy and autologous stem cell transplantation
Sclerosis, physical activity reduces mood disorders Protective effect against anxiety and depression
Multiple sclerosis, Epstein-Barr virus is a risk factor It is one of the causes of the onset of the autoimmune disease
Two ALS patients return to communicate The possibilities offered by a new software
Multiple sclerosis, effective new drugs Efficacy and safety of natalizumab
Multiple sclerosis, the difficulty of recognizing emotions Patients show difficulty in decoding intentions and moods
Stem cells for demyelinating diseases Blocked disease progression in many cases
New markers for ALS Useful for monitoring disease progress